SEC Comment Letter for PLIANT THERAPEUTICS, INC. (PLRX) (CIK 0001746473) (PLRX) — Jun 2, 2022

PLIANT THERAPEUTICS, INC. (PLRX) (CIK 0001746473)
Date: June 2, 2022 · CIK: 0001746473 · Accession: 0000000000-22-005971

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

June 2, 2022

Author

Keith Cummings

Form

UPLOAD

Company

PLIANT THERAPEUTICS, INC. (PLRX) (CIK 0001746473)

Letter

United States securities and exchange commission logo June 2, 2022 Keith Cummings Chief Financial Officer PLIANT THERAPEUTICS, INC. 260 Littlefield Avenue South San Francisco, CA 94080 Re:PLIANT THERAPEUTICS, INC. 10-K/A filed May 27, 2022 File No. 1-39303 Dear Mr. Cummings: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
June 2, 2022
Keith Cummings
Chief Financial Officer
PLIANT THERAPEUTICS, INC.
260 Littlefield Avenue
South San Francisco, CA 94080
Re:PLIANT THERAPEUTICS, INC.
10-K/A filed May 27, 2022
File No. 1-39303
Dear Mr. Cummings:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io